People: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

28.37USD
27 Aug 2014
Price Change (% chg)

$-0.18 (-0.63%)
Prev Close
$28.55
Open
$28.49
Day's High
$28.75
Day's Low
$28.34
Volume
30,576
Avg. Vol
242,868
52-wk High
$57.89
52-wk Low
$16.78

Search Stocks

Kumar, Ravindra 

Brief Biography

Dr. Ravindra Kumar, Ph.D. is Chief Scientific Officer, Vice President of Acceleron Pharma, Inc. He joined Acceleron in March 2004 and is currently our Vice President and Chief Scientific Officer. Dr. Kumar established and currently leads our discovery research. Previously, Dr. Kumar worked for 12 years at Genetics Institute and Wyeth Pharmaceuticals. At Genetics Institute, Dr. Kumar was a key member of the Small Molecule Drug Discovery group and was responsible for cell biology. Following the integration of discovery functions from GI and Wyeth Pharmaceuticals, Dr. Kumar served as Senior Scientist in the Biological Chemistry group. Dr. Kumar is the author of several key scientific manuscripts in the area of protein glycosylation and is named as an inventor of several patents. Dr. Kumar received his BS in chemistry from Rohilkhand University, his MS in chemistry from Meerut University, his Ph.D. from University of New Brunswick and he completed his post-doctoral fellowship at Albert Einstein College of Medicine, in Bronx, NY.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Knopf

2,633,880

Kevin McLaughlin

--

Steven Ertel

--

Matthew Sherman

999,216

Ravindra Kumar

--

John Quisel

910,219
As Of 30 Dec 2013
Search Stocks